Allarity Therapeutics
ALLR
16 hedge funds and large institutions have $1.4M invested in Allarity Therapeutics in 2025 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 1 closing their positions.
500% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 1
45% more funds holding
Funds holding: 11 → 16 (+5)
33% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 3
1.11% more ownership
Funds ownership: 7.07% → 8.18% (+1.1%)
15% less capital invested
Capital invested by funds: $1.63M → $1.4M (-$237K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$231K |
| 2 |
DS
DRW Securities
Chicago,
Illinois
|
+$156K |
| 3 |
CAI
Capital Advisors Inc
Tulsa,
Oklahoma
|
+$127K |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$42.9K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$33.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
-$285K |
| 2 |
Northern Trust
Chicago,
Illinois
|
-$18.7K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$12.2K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$10 |
ALLR Hedge Fund Activity: Q4 2025 in Review
16 of the 8,270 institutional investors tracked by Wall St. Rank reported a position in Allarity Therapeutics (ALLR) for Q4 2025, worth a combined $1.4M — down 15% from $1.63M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new ALLR positions and 1 closed out — a net gain of 5 holders — while 4 added to existing stakes and 3 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $231K. The largest seller was Private Advisor Group, cutting an estimated $285K.
- 16 institutional investors held Allarity Therapeutics (ALLR) as of Q4 2025, up from 11 in Q3 2025.
- Funds reported $1.4M of Allarity Therapeutics stock for Q4 2025, down 15% quarter-over-quarter.
- 6 funds opened new Allarity Therapeutics positions in Q4 2025 and 1 closed out, a net change of +5 holders.
- The largest Allarity Therapeutics buyer in Q4 2025 was Renaissance Technologies, an estimated $231K added.
- The largest Allarity Therapeutics seller in Q4 2025 was Private Advisor Group, an estimated $285K sold.
Based on aggregated 13F filings for Q4 2025.